VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

about

Current trials for frontline therapy of mantle cell lymphoma.Past, Present, and Future of Rituximab-The World's First Oncology Monoclonal Antibody Therapy.Current overview and treatment of mantle cell lymphoma

P2860

Q49279565-D577F4AF-DD74-4C9C-8A48-2283FDBC2D02 Q55283747-95AF8897-9BF3-41C8-8F78-976353A7F5FC Q57174710-33770957-C5AF-4E28-93D2-A79400E185EA

P2860

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

Item

http://www.wikidata.org/entity/Q48546805

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@en

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@nl

type

Item

label

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@en

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@nl

prefLabel

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@en

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@nl

P1476

VcR-CVAD Induction Chemotherap ...... consin Oncology Network Study.

@en

P2093

Anne M Traynor

http://www.w3.org/2001/XMLSchema#string

Brad S Kahl

http://www.w3.org/2001/XMLSchema#string

Christopher Peterson

http://www.w3.org/2001/XMLSchema#string

Jae E Werndli

http://www.w3.org/2001/XMLSchema#string

Jules Blank

http://www.w3.org/2001/XMLSchema#string

Julie E Chang

http://www.w3.org/2001/XMLSchema#string

KyungMann Kim

http://www.w3.org/2001/XMLSchema#string

Lakeesha L Carmichael

http://www.w3.org/2001/XMLSchema#string

Michael S Huie

http://www.w3.org/2001/XMLSchema#string

Michael Volk

http://www.w3.org/2001/XMLSchema#string

P2860

A phase 1/1b study of rituximab, bendamustine, and ibrutinib in patients with untreated and relapsed/refractory non-Hodgkin lymphoma.

Bortezomib-based therapy for newly diagnosed mantle-cell lymphoma.

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group.

Molecular remission is an independent predictor of clinical outcome in patients with mantle cell lymphoma after combined immunochemotherapy: a European MCL intergroup study

High rate of durable remissions after treatment of newly diagnosed aggressive mantle-cell lymphoma with rituximab plus hyper-CVAD alternating with rituximab plus high-dose methotrexate and cytarabine.

Long-term progression-free survival of mantle cell lymphoma after intensive front-line immunochemotherapy with in vivo-purged stem cell rescue: a nonrandomized phase 2 multicenter study by the Nordic Lymphoma Group

Treatment of older patients with mantle-cell lymphoma.

VcR-CVAD induction chemotherapy followed by maintenance rituximab in mantle cell lymphoma: a Wisconsin Oncology Network study.

Maintenance rituximab following induction chemo-immunotherapy for mantle cell lymphoma: long-term follow-up of a pilot study from the Wisconsin Oncology Network.

A phase II multicenter trial of hyperCVAD MTX/Ara-C and rituximab in patients with previously untreated mantle cell lymphoma; SWOG 0213.

P304

e61-e67

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.CLML.2017.10.006

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

David T Yang

P577

2017-11-04T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

29191715

http://www.w3.org/2001/XMLSchema#string

P932

5896779

http://www.w3.org/2001/XMLSchema#string

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

about

P2860

P2860

VcR-CVAD Induction Chemotherapy Followed by Maintenance Rituximab Produces Durable Remissions in Mantle Cell Lymphoma: A Wisconsin Oncology Network Study.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932

P356

P1433

P1476

P2093

P2860

P304

P31

P356

P407

P433

P478

P50

P577

P698

P932